|
|
MGN-3 is made from a polysaccharide derivative of rice bran, modified by enzymes of shiitake mushrooms. MGN-3 has been manufactured in Japan for the last 6 years and has been used by hundreds of doctors on tens of thousands of patients as a treatment for cancer. In no case has there been any report of side effects or toxicity.
Research indicates that MGN-3 works by stimulating the Natural Killer or NK cells in the immune system. These NK cells are the first line of defense against viral infections and cancer. After activation by MGN-3, when the NK cell encounters a tumor cell, it attaches itself to the tumor cell membrane and injects cytoplasmic granules into the tumor cell that dissolve it in about five minutes. The NK cell then moves to the next tumor cell and attacks it. An MGN-3 activated NK cell can destroy up to 27 cancer cells.
MGN-3 works best after debulking. Debulking is a therapy to eliminate most of the cancer cells. Examples of debulking include radiation, chemotherapy, and surgery. With debulking, you would hope to kill or remove 95-98% of the cancer cells. At this point, the patient would be termed "in remission." Unfortunately, too many of these remissions are short-lived and the cancer returns more resistant to treatment. MGN-3, when taken during the initial remission, activates the NK cells to eradicate stray tumor cells not killed by the debulking therapy.
Since each NK cell can only handle a limited number of cancer cells, MGN-3 should be taken in conjunction with debulking, rather than in place of debulking. The sheer numbers of cancer cells could otherwise overwhelm the number of activated NK cells. In addition to supporting the immune system in this battle, MGN-3 has been shown to reduce the side effects of the other treatments.
Copyright (c) 2001 by Chip Engelmann
|
